Suppr超能文献

[一例经手术切除及术后服用依维莫司成功治疗的巨大胰腺神经内分泌癌病例]

[A case of massive pancreatic neuroendocrine carcinoma successfully treated with surgical resection and postoperative everolimus administration].

作者信息

Mukai Yosuke, Takeda Yutaka, Nakahira Shin, Katsura Yoshiteru, Kusama Hiroki, Hashimoto Naoyoshi, Matsushita Katsunori, Kawashima Hiroshi, Hamanaka Michiko, Kagawa Yoshinori, Takeno Atsushi, Okishiro Masatsugu, Sakisaka Hideki, Suzuki Rei, Egawa Chiyomi, Taniguchi Hirokazu, Kato Takeshi, Tamura Shigeyuki

机构信息

Dept. of Surgery, Kansai Rosai Hospital.

出版信息

Gan To Kagaku Ryoho. 2013 Nov;40(12):1887-9.

Abstract

A 55-year-old woman presented to our hospital with a chief complaint of abdominal pain. Computed tomography (CT) revealed a massive tumor originating from the tail of the pancreas, with liver and lymph node metastasis. Percutaneous biopsy was performed and yielded a diagnosis of pancreatic neuroendocrine carcinoma. The patient underwent distal pancreatectomy, lateral segmentectomy of the liver, para-aortic lymph node dissection, and cytoreductive surgery for treatment of peritoneal dissemination. Octreotide was administered on post-operative day (POD) 3. Treatment with everolimus (10 mg/day) was initiated on POD 32. Stable disease according to the Response Evaluation Criteria in Solid Tumors( RECIST) was observed for 4 months, and the patient survived for a total of 9 months after surgery. Everolimus was tolerated safely and was effective for the treatment of pancreatic neuroendocrine carcinoma.

摘要

一名55岁女性因腹痛为主诉前来我院就诊。计算机断层扫描(CT)显示胰腺尾部有一个巨大肿瘤,并伴有肝和淋巴结转移。进行了经皮活检,诊断为胰腺神经内分泌癌。患者接受了胰体尾切除术、肝左外叶切除术、腹主动脉旁淋巴结清扫术以及针对腹膜播散的减瘤手术。术后第3天开始使用奥曲肽。术后第32天开始使用依维莫司(10毫克/天)治疗。根据实体瘤疗效评价标准(RECIST)观察到病情稳定4个月,患者术后共存活9个月。依维莫司耐受性良好,对胰腺神经内分泌癌治疗有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验